Viewing Study NCT03263650

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:58 PM
Ignite Modification Date: 2026-02-20 @ 1:32 PM
Study NCT ID: NCT03263650
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-22
First Post: 2017-08-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer Aggressiveness View
None Prostate Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None prostate cancer View
None genomic alterations View
None DNA damage repair View
None DDR pathway gene expression View
None aggressive-variant prostate carcinomas View
None small cell prostate carcinoma View
None neuroendocrine prostate carcinoma View